Learn how tirzepatide, a next‑generation dual GIP/GLP‑1 receptor agonist, uses advanced peptide engineering to deliver powerful glycemic control and bariatric‑level weight loss in type 2 diabetes, outperforming traditional GLP‑1 drugs.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs